Product fact sheet

Hooga PRO1500 Technical Profile

Name: Hooga PRO1500
Brand: Hooga

Technical Hooga PRO1500 specifications from the 2025 PRO-series manual, including a transparent note where current manufacturer surfaces disagree on power consumption.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Desk researchedFacts checked 2026-08-11

A 300-LED two-wavelength PRO-series panel. The current manual lists 530 W electrical consumption, which should not be silently substituted with differently dated web-chart values.

Fit signals

larger two-wavelength panel comparisons, readers auditing source-date discrepancies

Potential constraints

buyers requiring a single reconciled number where official sources conflict, buyers requiring independent output testing

Key tradeoff: Primary documentation is available, but conflicting manufacturer web figures make source dates especially important.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

Technical record

The 2025 PRO-series manual lists the PRO1500 at 36 × 8.6 × 3.1 inches, with 300 × 5 W dual-chip LEDs, 660 nm and 850 nm wavelengths, a 60° beam angle and AC 85–265 V input compatibility. It separates a 1500 W lamp-power label from 530 W power consumption.

A documented discrepancy

A current Hooga web comparison surface has also displayed a different PRO1500 consumption figure. The cited 2025 primary manual lists 530 W consumption, so the conflicting web value should remain visibly source-bounded rather than silently reconciled.

Evidence boundary

No independent measurements of this panel’s optical output, electrical draw, heat, fan noise or coverage are included in the current record. Manufacturer irradiance charts remain manufacturer evidence, not third-party verification.

For comparison, the 300-LED count, 36-inch height and dual 660/850 nm spectrum define the hardware class more reliably than the nominal 1500 W lamp label, which is not the same quantity as electrical consumption or optical output.

Technical specifications

Published specs and what they mean

Physical

Dimensions: 36 × 8.6 × 3.1 in

Optical

Wavelengths: 660 / 850 nm
LED quantity: 300 × 5 W dual-chip LEDs
Lamp power rating: 1500 W
Beam angle: 60°

Electrical

Power consumption: 530 W
Power input: AC 85–265 V

Environment

Operating temperature: 32–90°F

What the current record does not establish

Current manufacturer surfaces have published conflicting power-consumption figures; this record uses the cited 2025 manual and flags the discrepancy.
No independent common-protocol irradiance measurement is normalized.
No Homeapotherapy hands-on testing exists.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 660 / 850 nm.

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Use the current manufacturer instructions. Official Hooga sources have shown different PRO1500 consumption figures, so source date and measurement definition need to stay attached to the number.

The PRO-series manual contains device and eye-safety warnings.
Power figures from differently dated manufacturer sources should not be silently merged.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

Hooga PRO Series User ManualHooga · Manufacturer manual · PDF · retrieved 2026-08-11
Hooga Quality & Certifications: What We Can VerifyHooga · Manufacturer · retrieved 2026-08-10
Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10

Comparable products